S&P 500   4,622.44 (+0.39%)
DOW   36,404.93 (+0.43%)
QQQ   395.52 (+0.85%)
AAPL   193.18 (-1.29%)
MSFT   371.30 (-0.78%)
META   325.28 (-2.24%)
GOOGL   133.29 (-1.26%)
AMZN   145.89 (-1.04%)
TSLA   239.74 (-1.68%)
NVDA   466.27 (-1.85%)
NIO   7.68 (+4.07%)
BABA   71.37 (-1.07%)
AMD   134.41 (+4.26%)
T   16.62 (-1.77%)
F   11.07 (+0.54%)
MU   77.79 (+3.78%)
CGC   0.73 (-8.34%)
GE   120.28 (-0.26%)
DIS   92.20 (-0.67%)
AMC   7.11 (+2.60%)
PFE   28.64 (-0.49%)
PYPL   59.04 (+0.17%)
XOM   99.62 (+0.07%)
S&P 500   4,622.44 (+0.39%)
DOW   36,404.93 (+0.43%)
QQQ   395.52 (+0.85%)
AAPL   193.18 (-1.29%)
MSFT   371.30 (-0.78%)
META   325.28 (-2.24%)
GOOGL   133.29 (-1.26%)
AMZN   145.89 (-1.04%)
TSLA   239.74 (-1.68%)
NVDA   466.27 (-1.85%)
NIO   7.68 (+4.07%)
BABA   71.37 (-1.07%)
AMD   134.41 (+4.26%)
T   16.62 (-1.77%)
F   11.07 (+0.54%)
MU   77.79 (+3.78%)
CGC   0.73 (-8.34%)
GE   120.28 (-0.26%)
DIS   92.20 (-0.67%)
AMC   7.11 (+2.60%)
PFE   28.64 (-0.49%)
PYPL   59.04 (+0.17%)
XOM   99.62 (+0.07%)
S&P 500   4,622.44 (+0.39%)
DOW   36,404.93 (+0.43%)
QQQ   395.52 (+0.85%)
AAPL   193.18 (-1.29%)
MSFT   371.30 (-0.78%)
META   325.28 (-2.24%)
GOOGL   133.29 (-1.26%)
AMZN   145.89 (-1.04%)
TSLA   239.74 (-1.68%)
NVDA   466.27 (-1.85%)
NIO   7.68 (+4.07%)
BABA   71.37 (-1.07%)
AMD   134.41 (+4.26%)
T   16.62 (-1.77%)
F   11.07 (+0.54%)
MU   77.79 (+3.78%)
CGC   0.73 (-8.34%)
GE   120.28 (-0.26%)
DIS   92.20 (-0.67%)
AMC   7.11 (+2.60%)
PFE   28.64 (-0.49%)
PYPL   59.04 (+0.17%)
XOM   99.62 (+0.07%)
S&P 500   4,622.44 (+0.39%)
DOW   36,404.93 (+0.43%)
QQQ   395.52 (+0.85%)
AAPL   193.18 (-1.29%)
MSFT   371.30 (-0.78%)
META   325.28 (-2.24%)
GOOGL   133.29 (-1.26%)
AMZN   145.89 (-1.04%)
TSLA   239.74 (-1.68%)
NVDA   466.27 (-1.85%)
NIO   7.68 (+4.07%)
BABA   71.37 (-1.07%)
AMD   134.41 (+4.26%)
T   16.62 (-1.77%)
F   11.07 (+0.54%)
MU   77.79 (+3.78%)
CGC   0.73 (-8.34%)
GE   120.28 (-0.26%)
DIS   92.20 (-0.67%)
AMC   7.11 (+2.60%)
PFE   28.64 (-0.49%)
PYPL   59.04 (+0.17%)
XOM   99.62 (+0.07%)

EKF Diagnostics (EKF) Share Price, News & Analysis

GBX 27.30
-0.10 (-0.36%)
(As of 04:35 PM ET)
Compare
Today's Range
27
28.90
50-Day Range
26
29.10
52-Week Range
22.20
52.94
Volume
52,648 shs
Average Volume
725,687 shs
Market Capitalization
£123.87 million
P/E Ratio
N/A
Dividend Yield
3.66%
Price Target
N/A

EKF stock logo

About EKF Diagnostics Stock (LON:EKF)

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, the company provides clinical chemical analyzers, such as Beta-hydroxybutyrate for monitoring ketosis; Glycated Albumin; Glycated Serum Protein; Nitro-tab Ketone tablets; and Procalcitonin marker for bacterial infection and sepsis, as well as reagents, calibrators, standards, and controls. Additionally, it offers RaPET Serology immunoassay kits; QuStick Strep A for Strep A infection treatment; Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; and kits and other services related to COVID-19, as well as contract manufacturing solutions to third-party businesses and laboratory services. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.

EKF Stock Price History

EKF Stock News Headlines

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
EKF Diagnostics Holdings PLC (GB0031509804.SG)
EKF Diagnostics Shares Fall on Revenue Guidance Cut
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
EKF Diagnostics CFO to Step Down
Global PoC Diagnostics Market for Zika Virus
Hemoglobin Testing Global Market Report 2023
The Global Point of Care Diagnostics Market
Globally Pregnancy Test Market Growth Rate 2023
See More Headlines
Receive EKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKF Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 12/1 Dividend
11/02/2023
Dividend Payable
12/01/2023
Today
12/11/2023

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
356
Year Founded
N/A

Profitability

Net Income
£-12,670,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£56.04 million
Cash Flow
GBX 2.57 per share
Book Value
GBX 14 per share

Miscellaneous

Free Float
N/A
Market Cap
£123.87 million
Optionable
Not Optionable
Beta
0.61
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Julian Huw Baines M.B.E. (Age 58)
    Executive Chairman
    Comp: $84k
  • Mr. Stephen Young A.C.M.A. (Age 59)
    CFO & Director
  • Mr. Andrew Webb
    Chief Executive Officer of Ekf Molecular














EKF Stock Analysis - Frequently Asked Questions

How have EKF shares performed in 2023?

EKF Diagnostics' stock was trading at GBX 50 on January 1st, 2023. Since then, EKF stock has decreased by 45.4% and is now trading at GBX 27.30.
View the best growth stocks for 2023 here
.

How often does EKF Diagnostics pay dividends? What is the dividend yield for EKF Diagnostics?

EKF Diagnostics announced a dividend on Thursday, March 28th. Stockholders of record on Thursday, November 2nd will be given a dividend of GBX 1.20 per share on Friday, December 1st. This represents a dividend yield of 4.59%. The ex-dividend date is Thursday, November 2nd. The official announcement can be seen at this link.
Read our dividend analysis for EKF
.

Is EKF Diagnostics a good dividend stock?

EKF Diagnostics (LON:EKF) pays an annual dividend of GBX 1 per share and currently has a dividend yield of 4.18%. EKF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for EKF.

What other stocks do shareholders of EKF Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other EKF Diagnostics investors own include ERBA Diagnostics (ERBA), Kirkland Lake Gold (KLG), Telford Homes (TEF), ASOS (ASC), Advanced Computer Software Group (asw), boohoo group (BOO), Newmont (NEM), SolGold (SOLG), Arcontech Group (ARC) and Alliance Pharma (APH).

How do I buy shares of EKF Diagnostics?

Shares of EKF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:EKF) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -